Friday, February 6, 2009

Bitter Pill

Created to treat schizophrenia, Zyprexa wound up being used on misbehaving kids. How the pharmaceutical industry turned a flawed and dangerous drug into a $16 billion bonanza
by BEN WALLACE-WELLS

Excerpt:
"Eli Lilly insists that it has not marketed Zyprexa off-label and that it has accurately represented the drug's side effects. But some medical researchers who have studied the atypical antipsychotics say that, in the final tally, the drugs, which have already been linked to some deaths, may eventually be responsible for tens of thousands of cases of diabetes and other potentially fatal diseases. And despite their early promise for treating schizophrenia, the drugs have not even performed any better than the crude and imprecise earlier medications that preceded them. "We have been paying $16 billion a year instead of $2 billion a year for drugs that seem to be no better and might be worse," says Douglas Leslie, a researcher at the Medical University of South Carolina who contributed to an extensive federal study of the drugs."

Full Article and Source:
Bitter Pill - Rolling Stone Magazine

See also:

1 comment:

  1. Drug companies routinely ask for forgiveness instead of permission.

    By the time they get caught, they've more than made a killing --including plenty of money to pay the fines they know they'll be accessed and still have record profits.

    ReplyDelete